ArticleChembiochem : a European journal of chemical biology2026
Sustainable Synthesis of Bio-Based Furanic and Aromatic Amines Using an Optimized Whole-Cell Transaminase-Decarboxylase Cascade in E. coli RARE.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sustainable Synthesis of Bio-Based Furanic and Aromatic Amines Using an Optimized Whole-Cell Transaminase-Decarboxylase Cascade in E. coli RARE.Chembiochem : a European journal of chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The development of efficient biocatalytic routes for synthesizing primary amines is often hindered by the unfavorable thermodynamic equilibrium of enzymatic transamination. In this study, we present a highly effective bienzymatic cascade coupling the (S)-selective ω-transaminase from Pseudomonas psychrotolerans (PpS-TA) with pyruvate decarboxylase from Zymomonas mobilis (ZmPDC). This integrated system uses ZmPDC to irreversibly remove the pyruvate coproduct, thereby shifting the equilibrium toward the desired amine. Optimization of the purified enzyme system resulted in a twofold increase in conversion compared to the transaminase alone. The cascade exhibited broad substrate scope across various substituted benzaldehydes and simultaneously enabled the formation of valuable (R)-acyloin byproducts through the carboligation activity of ZmPDC. To enhance industrial applicability, the cascade was transferred to a whole-cell system using an engineered Escherichia coli strain (RARE), which minimizes undesired endogenous aldehyde reduction. The coexpressed whole-cell biocatalyst exhibited superior productivities at substrate loadings up to 50 mM without the need for organic cosolvents. Finally, the utility of this approach was demonstrated through the chemo-enzymatic synthesis of the bio-based platform molecule 2,5-bis(aminomethyl)furan from d-fructose, achieving an exceptional 90% conversion on a 500-mL preparative scale. This integrated strategy provides a sustainable and scalable framework for producing high-value aromatic and furanic amines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.